Background: Autologous fat grafting is commonly used for soft-tissue augmentation and reconstruction. However, this technique is limited by a high rate of graft absorption. Thus, approaches to improve fat graft survival that promote neovascularization are of great interest. Nanofat has several beneficial features that may render it more suitable for clinical applications than other stem-cell based approaches. Objectives: We aimed to determine whether nanofat could enhance new vessel formation and improve the long-term retention of fat grafts. Methods: Nanofat was processed via mechanical emulsification and filtration. Fat grafts were transplanted subcutaneously under the scalps of nude mice with different nanofat volumes or without nanofat. The grafted fat was dissected 12 weeks after transplantation. Graft weight and volume were measured, and histological evaluations, including capillary density measurement, were performed. Results: The co-transplantation of fat with nanofat showed higher graft weight and volume retention, better histological structure, and higher capillary density compared to that in controls. However, there were no significant differences between the two nanofat volumes utilized. Conclusions: Nanofat can enhance neovascularization and improve fat graft survival, providing a potential clinically viable approach to fat graft supplementation in plastic and reconstructive surgery.
Soft tissue augmentation, reconstruction, and recontouring are increasingly popular topics in plastic surgery. Autologous adipose tissue is readily available, inexpensive, biocompatible, and easily obtainable, and has been widely used as an ideal filler in the treatment of soft-tissue defects for both aesthetic and reconstructive purposes. 1, 2 However, the highly unpredictable absorption rate of grafts following transplantation is still a major concern. The survival rate of grafted fat is reported to vary from 20% to 80%. 3, 4 Previous studies have revealed that adequate neovascularization in the graft is crucial for the survival and long-term maintenance of the grafted fat. [5] [6] [7] Accordingly, approaches that stimulate neovascularization have been developed to improve graft survival, including the co-transplantation of fat with proangiogenic growth factors, such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF), etc. [8] [9] [10] Recent studies have demonstrated that the co-transplantation of fat with adipose tissue-derived stem cells (ADSCs), as well as adipose tissue-derived stromal vascular fraction (SVF) cells, could improve the survival of fat grafts, either through paracrine effects or direct differentiation into adipocytes. 11, 12 Thus, the stem cell-based approach is developing into a real solution in fat transplantation. However, the collection of ADSCs or SVF cells for clinical applications is still complicated and time consuming, and safety concerns exist. 13, 14 Nanofat, an emulsified suspension derived from fat tissue that is processed by purely mechanical means and has been used for skin rejuvenation purposes, was first reported in Tonnard et al. 15 Subsequent studies have demonstrated that nanofat contains a large amount of ADSCs that retain an extensive proliferative and multipotent differentiation capacity. 16, 17 Since nanofat processing does not involve any chemicals or enzymes, and the whole procedure can be finished within several minutes, nanofat may be more suitable for clinical applications than other methods for collecting ADSCs and SVF cells. Therefore, the aim of the current study is to investigate whether the co-transplantation of nanofat could improve fat graft survival.
METHODS

Adipose Tissue Harvesting and Nanofat Processing
Adipose tissue was aspirated from the lower abdomen of five healthy female donors via standard vacuum-assisted liposuction from January 2017 to June 2017. All donors were healthy women (smokers and patients with diabetes mellitus, vascular diseases, and cardiac problems were excluded). The mean age was 35 years (range, 25-38 years). The BMI of the donors was not calculated. Written informed consent to use the lipoaspirate for analysis was obtained from each donor. The study protocol was approved by the Ethics Committee of Shanghai Jiaotong University School of Medicine, Shanghai, China. After the infiltration of a modified Klein solution containing 800 mg/L lidocaine and 1:1,000,000 unit dilution of adrenaline into the lower abdomen, lipoaspirates were separately harvested by means of a 3-mm liposuction cannula with large side holes of 2 × 7 mm (aspirated adipose tissue, "macrofat") and a 3-mm multiport cannula with several side holes of 1-mm diameter (aspirated adipose tissue, "microfat"). Upon completion of adipose tissue harvesting, the macrofat and microfat were rinsed with sterile phosphate-buffered saline solution (PBS) in closed syringes. During approximately 10 minutes of decantation, the lipoaspirate naturally separated into 3 layers. The superior oily and inferior fluid layers were discarded; the middle layer was collected for further processing.
Nanofat processing was achieved using Tonnard's technique. 15 Firstly, the microfat lipoaspirate was filtered through a sterile nylon cloth with 0.5-mm pores. The fat was then mechanically emulsified via 30 passes of shifting between two 10-cc syringes connected to each other by a female-to-female Luer-Lock connector. After the fragmentation process, the fat became liquid and was again filtered through the nylon cloth as above. The obtained effluent is known as "nanofat." The processed macrofat and nanofat were stored at 4°C for later use.
Adipocyte Viability in Macrofat and Nanofat
Adipocyte viability in macrofat and nanofat was detected by a live/dead staining. In brief, the fat samples were stained with calcein-AM solution (2 μmol/L) and propidium iodide (4.5 μmol/L) (Yeasen, Shanghai, China) for 10 minutes. The lipoaspirates were observed under fluorescence microscopy (Carl Zeiss, Oberkochen, Germany), with a 490-nm excitation filter for viable adipocytes and a 525-nm excitation filter for dead adipocytes.
Enzyme-Linked Immunosorbent Assay
Enzyme-linked immunosorbent assays (ELISAs) were utilized to quantify the levels of VEGF, PDGF, bFGF, transforming growth factor-β (TGF-β), hepatocyte growth factor (HGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and insulin-like growth factor-1 (IGF-1) in the nanofat. Assays followed standard ELISA protocols and concentration values were recorded.
Animal Model and Groups
The animal care and study protocol were approved by the Animal Care and Experiment Committee of Shanghai Jiaotong University School of Medicine. Thirty 4 to 6 weekold female BALB/c-nu nude mice (weight, 13-16 g; Animal Laboratory, The Ninth People's Hospital, Shanghai Jiaotong University School of medicine, Shanghai, China) were obtained. The mice were housed in a temperature-controlled environment of 24 ± 2°C, with an artificial 12-h light/dark cycle. The mice were randomly assigned to one of the following groups (n = 10 in each group): Control, Nano100, and Nano200 groups. Briefly, the mice were all numbered and the random numbers were copied one by one in order from a random number table beneath each mouse. Then, the mice were grouped by putting the mice with numbers between 1 and 10 into the Control group, numbers between 11 and 20 into the Nano100 group, and the remaining mice into the Nano200 group. Fat grafts were injected via 14-G needles beneath the scalp. Mice in the Control group were injected with a mixture of 1 mL macrofat and 200 μL PBS. Mice in the Nano100 group were injected with a mixture of 1 mL macrofat, 100 μL nanofat, and 100 μL PBS. Mice in the Nano200 group were injected with 1 mL macrofat and 200 μL nanofat.
Sample Collection and General Measurement
The mice were humanely killed at 12 weeks after transplantation, and the grafts were carefully dissected from their scalps. Each sample was photographed and immediately weighed on an electronic balance. Tissue volumes were measured using the liquid overflow method; the graft was put into a syringe filled with PBS and the graft volume was recorded as the increase in the liquid level.
Histological Evaluation
Harvested fat grafts were fixed in 4% paraformaldehyde for 24 hours and embedded in paraffin for sectioning. Tissue sections from the center of the dissected fat were stained with hematoxylin-eosin (HE) and Masson's trichrome for analysis. Histological parameters were examined under a light microscope (Nikon Eclipse 90i, Japan) and were evaluated using the methods in Shoshani et al, 7 which included an assessment of fat graft integrity, as evidenced by the presence of intact and nucleated adipocytes; the presence of cysts and vacuoles; the intensity of inflammation proved by the infiltration of lymphocytes and macrophages; and the extent of fibrosis and other components of connective tissue. Each parameter was graded by two observers in a double-blinded fashion on a semiquantitative scale ranging from 0 to 5 (0 = absence; 1 = minimal presence; 2 = minimal to moderate presence; 3 = moderate presence; 4 = moderate to extensive presence; and 5 = extensive presence).
Assessment of Capillary Density
The paraffin-embedded sections were stained via immunohistochemistry. The sections were primarily incubated with anti-CD31 antibody (Abcam, Cambridge, United Kingdom), followed by incubation with horseradish peroxidase conjugated secondary antibody. Finally, the staining color was developed using the DAB Detection Kit (Maixin, Fuzhou, China). Five random fields from each sample (n = 3/group) were selected for observation under a light microscope (Nikon Eclipse 90i, Japan). The central part of the section was determined as field 1. After that, the slide was moved 2 fields up, down, right, or left to determine fields 2 to 5. The number of CD31-positive capillaries was counted using Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda, MD).
Statistical Analysis
Data are presented as mean ± standard deviation. Differences between groups were evaluated using one-way analyses of variance or t tests (SPSS Inc., Chicago, IL). P values of <0.05 were considered statistically significant.
RESULTS
Nanofat Characterization
After the emulsification process, the nanofat was generally observed as having the appearance of a whitish fatty liquid without connective tissue ( Figure 1A) . Calcein AM/ propidium iodide staining revealed that most adipocytes were viable in the macrofat, with a grape-like structure. Comparatively, fewer viable adipocytes were observed in the nanofat, with more propidium iodide-positive dead cells ( Figure 1B,C) .
The ELISAs revealed that VEGF (201.6 ± 35.6 pg/mL), PDGF (212.4 ± 24.9 pg/mL), HGF (121.8 ± 11.3 pg/mL), TGF-β (98.2 ± 18.8 pg/mL), bFGF (40.1 ± 18.4 pg/mL), IGF-1 (18.2 ± 4.0 pg/mL), and GM-CSF (19.6 ± 3.2 pg/ mL) were present in the nanofat, as shown in Figure 1D .
Fat Graft Survival Assessment
The grafts were harvested 12 weeks after fat transplantation. On gross observation, the nanofat co-transplantation groups had larger graft sizes compared to that in the Control group (Figure 2A ). This was confirmed in the weight and volume measurements of the grafts, with significantly greater weight and volume in the nanofat groups compared to that in the Control group (P < 0.05) ( Figure 2B,C) . However, there were no significant differences between the two nanofat groups. The mean sample weight was 0.24 ± 0.04, 0.35 ± 0.05, 0.29 ± 0.06 (g), and the mean volume was 0.24 ± 0.06, 0.4 ± 0.03, 0.29 ± 0.04 (mL), in the Control, Nano100, and Nano200 groups, respectively.
Histological Evaluation
HE and Masson's trichrome staining revealed that the fat grafts in the nanofat groups exhibited better survival and morphologic integrity compared to the Control group, as shown in Figure 3 . Extensive cystic changes and fibrous septa were observed in the Control group. There were significant differences between the nanofat groups and Control group in the histological evaluation of integrity, cysts/vacuoles, fibrosis, and inflammation (P < 0.05) ( Table 1) .
Assessment of Capillary Density
Since certain levels of proangiogenic growth factors were observed in the nanofat ( Figure 1D ), it is likely that the nanofat improved the graft survival by stimulating angiogenesis. To test this hypothesis, capillary density within the grafts was measured via immunohistochemical staining of anti-CD31 antibody in tissue sections. The number of CD3-positive vessels in the Nano100 (25.8 ± 3.5) and Nano200 groups (24.6 ± 4.72) were significantly higher compared to the Control group (10.4 ± 2.88) (P < 0.05), with no significant differences between the two nanofat groups (Figure 4 ).
DISCUSSION
The long-term retention rate of fat grafts using former transplantation techniques remains poor and unpredictable. Many factors can affect the viability and quality of the retained fat, including the various harvesting, processing, and injection techniques, which have been well reviewed by Suszynski et al. 18 The exact theoretical basis for fat graft survival remains controversial. During the aspiration process prior to the fat transplantation, the majority of blood microvessels in the fat grafts are destroyed. 19 Therefore, the fat grafts suffer in an ischemia phase after transplantation. Successful revascularization in this early stage could decrease adipocyte degeneration and fat tissue resorption. 20 Recently, stem cell-based approaches have been investigated. Matsumoto et al 21 first introduced the cell-assisted lipotransfer method, and provided evidence that transplanting fat with ADSCs improves survival. In addition, ADSCs have been shown to improve fat graft viability by enhancing angiogenesis. 11 ADSCs have the paracrine ability to secrete proangiogenic growth factors such as VEGF, HGF, and TGF-β, [22] [23] [24] which explains their ability to improve fat graft survival. Similar improvements have been observed for the co-transplantation of fat with SVF cells. 12 Nanofat is a natural emulsified suspension derived from fat tissue, and has been used for several clinical (B) Weight of the fat grafts 12 weeks after transplantation. Significant differences were found between the Control group and the Nanofat groups, but not between the Nano100 and Nano200 groups. (C) Volume of the fat grafts 12 weeks after transplantation. Significant differences were found between the Control group and the Nanofat groups, but not between the Nano100 and Nano200 groups. *P < 0.05.
applications allied to its regenerative potential. 15, 16, 25, 26 Several studies have focused on the cellular components of nanofat. Tonnard et al 15 successfully isolated abundant SVF cells and cultured functional ADSCs from nanofat. According to their research, the number of viable stem cells derived from the stromal vascular fraction was 1.98 × 10 6 cells/100 mL nanofat, and the number of CD34 + cells in the stromal vascular fraction was 0.1 × 10 6 cells/100 mL nanofat. Banyard et al 17 also noted the presence of endothelial progenitor cells, multipotent mesenchymal stem cells, and multilineage differentiating stress-enduring cells in nanofat. The authors observed that adipose-derived stem cells constitute 3.11% ± 0.8% of nanofat, which is approximately a 3-fold increase over that in standard lipoaspirate. Although we observed viable cells in nanofat, we have not yet characterized the constituents in detail. We speculated that viable cells within the nanofat might stimulate angiogenesis and improve fat survival. In order to minimize the number of animals used in this study, we only evaluated the outcomes at 3 months posttransplantation. To avoid the contamination of surrounding recipient subcutaneous tissue, fat grafts were injected beneath the scalp where almost no mice fat exists in this area. The fat grafts could be easily discriminated from surrounding tissue. Therefore, the dissection variability would not impact on the size of the final graft size. Twelve weeks after transplantation, the tissue volumes and weights of the grafted fat in the two nanofat co-transplantation groups were both significantly greater compared to that in the Control group (Figure 2) . Moreover, both HE and Masson's trichrome staining showed a better histological morphology and fat integrity in the nanofat co-transplantation groups compared to that in the Control group, as well as a smaller presence of cyst/vacuoles, extent of fibrosis, and inflammation ( Figure 3 , Table 1 ). In addition, more CD31-positive capillaries were observed in the nanofat co-transplantation groups compared to that in the Control group. This enhanced neovascularization could be explained by the presence of proangiogenic growth factors in nanofat ( Figure 1D ). It could also be explained by the presence of stem cells in nanofat. Interestingly, fat survival in the Nano200 group was not better than that in the Nano100 group. According to a previous study by Li et al, 27 fat grafts with a larger ADSC density have worse survival compared to that for grafts with an optimal density of 10 5 /mL ADSCs. Similarly, Paik et al 28 demonstrated that the oversupplementation of SVF cells may decrease fat graft retention by increasing metabolic load. In the present study, nanofat was freshly processed using mechanical methods, and contained various SVF subpopulations; thus, a majority of the cellular components were not ADSCs. Therefore, we assume that cells other than ADSCs in the nanofat may not benefit fat graft survival. In addition, a large amount of lipid droplets releasing from the destroyed adipocytes may not be beneficial for graft survival. Further studies are undoubtedly needed to evaluate separated fractions of nanofat based on these hypotheses.
Study Limitations
The present study has some limitations. Firstly, we have not yet characterized the constituent in nanofat; thus, we do not know the amount of SVF cells, ADSCs, and adipocytes in nanofat. In addition, as we did not label the nanofat before transplantation, we cannot tell whether nanofat adipocytes survived, or whether nanofat stem cells differentiated into adipocytes and/or participated in new vessel formation. Further studies using tagged nanofat (eg, with transgenic mice, in which cells express green fluorescent protein) could possibly address the above questions. 29 A B D C Figure 4 . Immunohistologic staining of the fat grafts 12 weeks after transplantation. (A) Anti-CD31 staining of grafts in the Control group. (B) Anti-CD31 staining of grafts in the Nano100 group. (C) Anti-CD31 staining of grafts in the Nano200 group. Angiogenesis is observed via anti-CD31 staining. Scale bars = 100 μm. (D) The number of CD31-positive vessels per optical field. The fat grafts of the nanofat groups had significantly more vessels compared to that in the control group, with no significant difference between the Nano100 and Nano200 groups. *P < 0.05.
Another weakness of this study is that fat graft survival was measured only by graft weight, volume, and histology, which are semiquantitative and somewhat operator dependent. Therefore, more accurate measurements, such as that achieved with magnetic resonance imaging, could be utilized in the future studies, especially in clinic trails.
CONCLUSIONS
To the best of our knowledge, the current study is the first to supplement fat grafting with nanofat. In contrast to ADSCs, SVF, and other stem cells commonly used in promoting fat graft survival, [30] [31] [32] nanofat is a natural functional cellular component, with simple and quick processing procedures (it takes about 20 minutes to achieve 10 mL of nanofat, including 15 minutes for liposuction and 5 minutes for filtering and emulsifying), and without the risk of chemical and enzyme contamination. The observed improvement in fat graft survival via co-transplantation with nanofat suggests that nanofat is potentially useful for clinical applications.
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